Stock BDRX BIODEXA PHARMACEUTICALS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Biodexa Pharmaceuticals Plc

Equities

BDRX

US59564R7089

Market Closed - Nasdaq
Other stock markets
 16:30:01 2024-05-03 EDT 		5-day change 1st Jan Change
1.18 USD -4.84% Intraday chart for Biodexa Pharmaceuticals Plc -9.23% -55.97%
05-03 European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower MT
05-02 European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading MT

Evolution of the average Target Price on Biodexa Pharmaceuticals Plc

Price target over the last 5 years

History of analyst recommendation changes

83f945e6e65e05cd634fcb84ec490b70.X5c4RSaQX-WFtXzV5tu8i2QmZBf9o3KqHjdkaVbeU1c.L8F9PxKibK_txSa4qOqN7SlUBlaiyxfweXs3Ax-6ajsNwncDVNkPsNHlPQ~9ebb1183c7998dc59a1294972bf94746

Analyst Recommendations on Biodexa Pharmaceuticals Plc

Ladenburg Thalmann Starts Biodexa Pharmaceuticals With Buy Rating, $8 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9402 GBP
Average target price
6.337 GBP
Spread / Average Target
+574.01%
High Price Target
6.337 GBP
Spread / Highest target
+574.01%
Low Price Target
6.337 GBP
Spread / Lowest Target
+574.01%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Biodexa Pharmaceuticals Plc

Ladenburg Thalmann

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BDRX Stock
  4. Consensus Biodexa Pharmaceuticals Plc